Comparison between ABCD and IMS scores in prediction of long-term T2DM remission after metabolic surgery in East Asian obese patients

Not Applicable

• Conditions: Obesity with type 2 diabetes

• Registration Number: JPRN-UMIN000037180
• Lead Sponsor: Oita University

Brief Summary

he two scoring systems were significantly well correlated. The IMS scoring system showed significant differences in T2DM remission rates between the procedures in the moderate stage, but the ABCD score showed no significant differences in each category. The discrimination power of the IMS score was comparable to that of the ABCD score at both 3 and 5 years. The revised IMS scoring system showed that SG-DJB had significantly higher T2DM remission rates in the moderate stage at 5 years than RYGB or SG.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-07-01
• Study Completion: 2020-06-30
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 24

Inclusion Criteria

Not provided

Exclusion Criteria

Patients who are not diagnosed as T2DM before operation Patients who have no data of preoperative C-peptide Patients who experienced severe complications such as leakage just after the first operation Patients who received revision surgery within 3 years after the first operation Patients who received pregnancy within 3 years after the first operation Patients who have lack of 3 years data (between 3-4 years) Patients who received other operations than SG, RYGB, resectional RYGB, mini-gastric bypass, and SG-DJB Patients who received open metabolic surgery (not laparoscopic) When patients experienced revision surgery or pregnancy between 4-5 years, 5 years data are only excluded.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Which scoring system is better in prediction of T2DM remission in East Asian obese patients 3 and 5 years after metabolic surgery?

Secondary Outcome Measures

Name	Time	Method
Who were good candidates for sleeve gastrectomy in East Asian countries? What is the better borderline point between mild and moderate stages in IMS score in East Asian countries?